Gene therapy for type 1 diabetes: Is it ready for the clinic?

Immunologic Research

Volumn 36, Issue 1-3, 2006, Pages 83-89

  D'Anneo, Antonella ^a,b,c   Rood, Pleunie ^a,b   Bottino, Rita ^a,b   Balamurugan, A N ^a,b   He, Jing ^a,b   Giannoukakis, Nick ^a,b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

Autoimmunity; Diabetes; Gene therapy; Immunotherapy

Indexed keywords

ADENOVIRUS VECTOR; INSULIN; PARVOVIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; ALLOGRAFT; CELL DIFFERENTIATION; HUMAN; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; STEM CELL; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

EID: 33947188722     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/ir:36:1:83     Document Type: Review

References (62)

1. Boyle JP, Honeycutt AA, Narayan KM, et al: Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care 2001;24:1936-1940.
2. LeRoith D, Smith DO: Monitoring glycemic control: the cornerstone of diabetes care. Clin Ther 2005;27:1489-1499.
3. Faideau B, Larger E, Lepault F, Carel JC, Boitard C: Role of {beta}-cells in type 1 diabetes Pathogenesis. Diabetes 2005;54(Suppl 2):S87-96.
4. Bottino R, Trucco M: Multifaceted therapeutic approaches for a multigenic disease. Diabetes 2005;54:S79-S86.
5. Giannoukakis N, Robbins PD: Gene and cell therapies for diabetes mellitus: strategies and clinical potential. BioDrugs 2002;16:149-173.
6. Bottino R, Lemarchand P, Trucco M, Giannoukakis N: Gene- and cell-based therapeutics for type I diabetes mellitus. Gene Ther 2003;10:875-889.
7. Giannoukakis N, Trucco M: Gene therapy technology applied to disorders of glucose metabolism: promise, achievements, and prospects. Biotechniques 2003;35:122-145.
8. Giannoukakis N, Trucco M: Current status and prospects for gene and cell therapeutics for type 1 diabetes mellitus. Rev Endocr Metab Disord 2003;4:369-380.
9. Kovesdi I, Brough DE, Bruder JT, Wickham TJ: Adenoviral vectors for gene transfer. Curr Opin Biotechnol 1997;8:583-589.
10. Yeh P, Perricaudet M: Advances in adenoviral vectors: from genetic engineering to their biology. FASEB J 1997;11:615-623.
11. Kochanek S: Development of high-capacity adenoviral vectors for gene therapy. Thromb Haemost 1999;82:547-551.
12. Kochanek S: High-capacity adenoviral vectors for gene transfer and somatic gene therapy. Hum Gene Ther 1999;10:2451-2459.
13. Seth P: Adenoviral vectors. Adv Exp Med Biol 2000;465:13-22.
14. St George JA: Gene therapy progress and prospects: adenoviral vectors. Gene Ther 2003;10:1135-1141.
15. Cao H, Koehler DR, Hu J: Adenoviral vectors for gene replacement therapy. Viral Immunol 2004;17:327-333.
16. Schagen FH, Ossevoort M, Toes RE, Hoeben RC: Immune responses against adenoviral vectors and their transgene products: a review of strategies for evasion. Crit Rev Oncol Hematol 2004;50:51-70.
17. Volpers C, Kochanek S: Adenoviral vectors for gene transfer and therapy. J Gene Med 2004;6 Suppl 1:S164-171.
18. Lai CM, Lai YK, Rakoczy PE: Adenovirus and adeno-associated virus vectors. DNA Cell Biol 2002;21:895-913.
19. Grimm D, Kay MA: From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy. Curr Gene Ther 2003;3:281-304.
20. Stilwell JL, Samulski RJ: Adeno-associated virus vectors for therapeutic gene transfer. Biotechniques 2003;34:148-150, 152, 154 passim.
21. Sun JY, Anand-Jawa V, Chatterjee S,Wong KK: Immune responses to adeno-associated virus and its recombinant vectors. Gene Ther 2003;10:964-976.
22. Buning H, Braun-Falco M, Hallek M: Progress in the use of adeno-associated viral vectors for gene therapy. Cells Tissues Organs 2004;177:139-150.
23. Carter BJ: Adeno-associated virus and the development of adeno-associated virus vectors: a historical perspective. Mol Ther 2004;10:981-989.
24. Conlon TJ, Flotte TR: Recombinant adeno-associated virus vectors for gene therapy. Expert Opin Biol Ther 2004;4:1093-1101.
25. Daly TM: Overview of adeno-associated viral vectors. Methods Mol Biol 2004;246:157-165.
26. Flotte TR: Gene therapy progress and prospects: recombinant adeno-associated virus (rAAV) vectors. Gene Ther 2004;11:805-810.
27. McCarty DM,Young SM, Jr, Samulski RJ: Integration of adeno-associated virus (AAV) and recombinant AAV vectors. Annu Rev Genet 2004;38:819-845.
28. Wang CH, Liu DW, Tsao YP, Xiao X, Chen SL: Can genes transduced by adeno-associated virus vectors elicit or evade an immune response? Arch Virol 2004;149:1-15.
29. Romano G: Current development of adeno-associated viral vectors. Drug News Perspect 2005;18:311-316.
30. Snyder RO, Francis J: Adeno-associated viral vectors for clinical gene transfer studies. Curr Gene Ther 2005;5:311-321.
31. Zaiss AK, Muruve DA: Immune responses to adeno-associated virus vectors. Curr Gene Ther 2005;5:323-331.
32. Raper SE, DeMatteo RP: Adenovirus-mediated in vivo gene transfer and expression in normal rat pancreas. Pancreas 1996;12:401-410.
33. Flotte T, Agarwal A,Wang J, et al: Efficient ex vivo transduction of pancreatic islet cells with recombinant adeno-associated virus vectors. Diabetes 2001;50:515-520.
34. Loiler SA, Tang Q, Clarke T, et al: Localized gene expression following administration of adeno-associated viral vectors via pancreatic ducts. Mol Ther 2005;12:519-527.
35. Wang Z, Zhu T, Rehman KK, et al: Widespread and stable pancreatic gene transfer by AAV vectors via different routes. Diabetes 2006;55:875-884.
36. Ayuso E, Chillon M, Garcia F, et al: In vivo gene transfer to healthy and diabetic canine pancreas. Mol Ther 2005;13:747-755.
37. McClane SJ, Chirmule N, Burke CV, Raper SE: Characterization of the immune response after local delivery of recombinant adenovirus in murine pancreas and successful strategies for readministration. Hum Gene Ther 1997;8:2207-2216.
38. Shifrin AL, Auricchio A, Yu QC, Wilson J, Raper SE: Adenoviral vector-mediated insulin gene transfer in the mouse pancreas corrects streptozotocin-induced hyperglycemia. Gene Ther 2001;8:1480-1489.
39. Couzin J, Kaiser J: Gene therapy. As Gelsinger case ends, gene therapy suffers another blow. Science 2005;307:1028.
40. Somia N, Verma IM: Gene therapy: trials and tribulations. Nat Rev Genet 2000;1:91-99.
41. Hirano Y, Mitamura T, Tamura T, Ohara K, Mine Y, Noguchi H: Mechanism of FK506-induced glucose intolerance in rats. J Toxicol Sci 1994;19:61-65.
42. Uchizono Y, Iwase M, Nakamura U, Sasaki N, Goto D, Iida M: Tacrolimus impairment of insulin secretion in isolated rat islets occurs at multiple distal sites in stimulus-secretion coupling. Endocrinology 2004;145:2264-2272.
43. Shapiro AM, Geng Hao E, Lakey JR, Finegood DT, Rajotte RV, Kneteman NM: Defining optimal immunosuppression for islet transplantation based on reduced diabetogenicity in canine islet autografts. Transplantation 2002;74:1522-1528.
44. Bonner-Weir S, Sharma A: Pancreatic stem cells. J Pathol 2002;197:519-526.
45. Seaberg RM, Smukler SR, Kieffer TJ, et al: Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat Biotechnol 2004;22:1115-1124.
46. Suzuki A, Nakauchi H, Taniguchi H: Prospective isolation of multipotent pancreatic progenitors using flow-cytometric cell sorting. Diabetes 2004;53:2143-2152.
47. Trucco M: Regeneration of the pancreatic beta cell. J Clin Invest 2005;115:5-12.
48. Bonner-Weir S, Toschi E, Inada A, et al: The pancreatic ductal epithelium serves as a potential pool of progenitor cells. Pediatr Diabetes 2004;5(Suppl 2):16-22.
49. Zorina TD, Subbotin VM, Bertera S, et al: Recovery of endogenous beta cell function in autoimmune diabetes. Stem Cells 2003;21:377-388.
50. Zorina TD, Subbotin VM, Bertera S, et al: Distinct characteristics and features of allogeneic chimerism in the NOD mouse model of autoimmune diabetes. Cell Transplant 2002;11:113-123.
51. Solimena M, Dirkx R, Jr, Hermel JM, et al: ICA 512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules. EMBO J 1996;15:2102-2114.
52. Ikehara S, Ohtsuki H, Good RA, et al.: Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation. Proc Natl Acad Sci USA 1985;82:7743-7747.
53. von Herrath M, Homann D: Islet regeneration needed for overcoming autoimmune destruction - considerations on the pathogenesis of type 1 diabetes. Pediatr Diabetes 2004;5(Suppl 2):23-28.
54. Rood PP, Bottino R, Balamurugan AN, Fan Y, Cooper DK, Trucco M: Facilitating physiologic self-regeneration: a step beyond islet cell replacement. Pharm Res 2006;23:227-242.
55. Suarez-Pinzon WL, Yan Y, Power R, Brand SJ, Rabinovitch A: Combination therapy with epidermal growth factor and gastrin increases {beta}-cell mass and reverses hyperglycemia in diabetic NOD mice. Diabetes 2005;54:2596-2601.
56. Baeyens L, De Breuck S, Lardon J, Mfopou JK, Rooman I, Bouwens L: In vitro generation of insulin-producing beta cells from adult exocrine pancreatic cells. Diabetologia 2005;48:49-57.
57. Heremans Y,Van De Casteele M, in't Veld P, et al: Recapitulation of embryonic neuroendocrine differentiation in adult human pancreatic duct cells expressing neurogenin 3. J Cell Biol 2002;159:303-312.
58. Garcia-Ocana A, Takane KK, Syed MA, Philbrick WM, Vasavada RC, Stewart AF: Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass, and induces mild hypoglycemia. J Biol Chem 2000;275:1226-1232.
59. George M,Ayuso E, Casellas A, Costa C, Devedjian JC, Bosch F: Beta cell expression of IGF-I leads to recovery from type 1 diabetes. J Clin Invest 2002;109:1153-1163.
60. Guo Y, Lu Y, Houle D, et al: Pancreatic islet-specific expression of an insulin-like growth factor-I transgene compensates islet cell growth in growth hormone receptor gene-deficient mice. Endocrinology 2005;146:2602-2609.
61. Farilla L, Hui H, Bertolotto C, et al: Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats. Endocrinology 2002;143:4397-4408.
62. Rehman KK, Wang Z, Bottino R, et al: Efficient gene delivery to human and rodent islets with double-stranded (ds) AAV-based vectors. Gene Ther 2005;12:1313-1323.